子類別 專利 [0/12] 期刊論文 [121/122] 會議論文/會議摘要 [14/24] 鄰近社群 伍素瑩 [53/74] 其他 [58/60] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [19/20] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [32/43] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [24/24] 紀雅惠 [21/27] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 蔣維棠 [43/99] 謝興邦 [178/259] 趙宇生(2002-2013) [120/279] 郭靜娟 [51/57] 鄒倫 [28/68] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 陳炯東 [183/267] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群統計 近3年內發表的文件:14(8.86%) 含全文筆數:135(85.44%) 文件下載次數統計 下載大於0次:135(100.00%) 下載大於100次:129(95.56%) 檔案下載總次數:83125(1.46%) 最後更新時間: 2025-03-12 21:27 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 CDGSH iron sulfur domain 2 activato... CDGSH鐵硫結構域２活化劑及其用途 增加細胞吞噬作用之方法 항암 경구 제제 CXCR4 antagonist-loaded nanoparticl... Development of potent and selective... DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Development of a humanized antibody... Discovery of dual MER/AXL kinase in...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-50 / 158. (共7頁) << < 1 2 3 4 5 6 7 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2021-10-14	Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model	Journal of Medicinal Chemistry. 2021 Oct 14;64(19):14477-14497.
2021-08-01	DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity	Life Sciences. 2021 Aug 1;278:Article number 119574.
2021-05-19	Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins	Journal of Medicinal Chemistry. 2021 May 19;64(11):7312-7330.
2021-03-30	A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment	Proceedings of the National Academy of Sciences of the United States of America. 2021 Mar 30;118(13):Article number e2015433118.
2021-01	Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors	Chemical Biology and Drug Design. 2021 Jan;97(1):51-66.
2021-01	BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy	Translational Oncology. 2021 Jan;14(1):Article number 100897.
2021-01	Potent and orally active purine-based fetal hemoglobin inducers for treating Beta-thalassemia and sickle cell disease	European Journal of Medicinal Chemistry. 2021 Jan;209:Article number 112938.
2020-08	Artificial intelligence approach fighting COVID-19 with repurposing drugs	Biomedical Journal. 2020 Aug;43(4):355-362.
2020-08	Repurposing old drugs as antiviral agents for coronaviruses	Biomedical Journal. 2020 Aug;43(4):368-374.
2020-08	BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification	Cancer Research. 2020 Aug;80(16):1937.
2020-05	Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors	Bioorganic Chemistry. 2020 May;98:Article number 103689.
2020-04	BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine	Neuropharmacology. 2020 Apr;166:Article number 107678.
2020-02-18	Impacts of intralipid on nanodrug abraxane therapy and on the innate immune system	Scientific Reports. 2020 Feb 18;10:Article number 2838.
2020-02-10	Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors	Journal of Medicinal Chemistry. 2020 Feb 10;63(4):1642-1659.
2020-02-01	Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment	European Journal of Medicinal Chemistry. 2020 Feb 1;187:Article number 111915.
2019-12	Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia	Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-11-27	Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-10	Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer	Annals of Oncology. 2019 Oct;30(Suppl. 5):789.
2019-07-11	Linker optimization and therapeutic evaluation of phosphatidylserine-targeting zinc dipicolylamine-based drug conjugates	Journal of Medicinal Chemistry. 2019 Jul 11;62(13):6047-6062.
2019-07	BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 227.
2019-07	An Aurora kinase inhibitor BPR6K471 inhibits tumor growth and reduces the cancer stem cell-like properties of small cell lung cancer	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 3851.
2019-06-05	Delta-opioid receptor antagonist naltrindole reduces oxycodone addiction and constipation in mice	European Journal of Pharmacology. 2019 Jun 5;852:265-273.
2019-05	Synthesis and evaluation of novel 7H-pyrrolo-[2,3-d]pyrimidine derivatives as potential anticancer agents	Future Medicinal Chemistry. 2019 May;11(9):959-974.
2019-04-10	Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants	Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.

顯示項目26-50 / 158. (共7頁) << < 1 2 3 4 5 6 7 > >> 每頁顯示[10|25|50]項目